Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1525 of 2873 entries
View as:

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Phase: N/A Priority: Normal
NCT ID: NCT01512589 Org: User:
Start: 04/30/12 End: 04/30/27 Due: 04/30/28

Measuring Surgical Recovery After Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT03193970 Org: User:
Start: 04/30/15 End: 12/31/34 Due: 12/31/35

Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03707938 Org: User:
Start: 12/18/18 End: 01/28/26 Due: 01/28/27

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05075993 Org: User:
Start: 11/12/21 End: 02/02/27 Due: 02/02/28

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)

Phase: N/A Priority: Normal
NCT ID: NCT01570868 Org: User:
Start: 04/30/12 End: 05/31/16 Due: 05/31/17

Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT00267085 Org: User:
Start: 12/31/05 End: 07/31/08 Due: 07/31/09

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03360721 Org: User:
Start: 03/06/18 End: 04/30/27 Due: 04/30/28

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02945579 Org: User:
Start: 01/20/17 End: 01/31/26 Due: 01/31/27

Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03147612 Org: User:
Start: 02/08/18 End: 02/28/27 Due: 02/28/28

NOV-002 in Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00960726 Org: User:
Start: - End: - Due: -

Doxil, Bevacizumab and Temsirolimus Trial

Phase: N/A Priority: Normal
NCT ID: NCT00761644 Org: User:
Start: 08/21/08 End: 03/28/19 Due: 03/28/20

Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06369259 Org: User:
Start: 02/24/25 End: 02/01/28 Due: 02/01/29

Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05645718 Org: User:
Start: 07/14/23 End: 12/31/29 Due: 12/31/30

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00698009 Org: User:
Start: 06/30/08 End: 06/30/12 Due: 06/30/13

SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

Phase: N/A Priority: Normal
NCT ID: NCT04599140 Org: User:
Start: 10/14/20 End: 01/31/26 Due: 01/31/27

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03021486 Org: User:
Start: 06/05/17 End: 06/30/27 Due: 06/30/28

Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation

Phase: N/A Priority: Normal
NCT ID: NCT06840262 Org: User:
Start: 08/10/20 End: 02/02/27 Due: 02/02/28

Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT01029509 Org: User:
Start: 07/31/08 End: 08/31/11 Due: 08/31/12

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Phase: N/A Priority: Normal
NCT ID: NCT05092373 Org: User:
Start: 04/29/22 End: 09/01/26 Due: 09/01/27

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Phase: N/A Priority: Normal
NCT ID: NCT04575935 Org: User:
Start: 08/05/20 End: 12/31/28 Due: 12/31/29

Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

Phase: N/A Priority: Normal
NCT ID: NCT00452374 Org: User:
Start: 11/30/04 End: 01/31/11 Due: 01/31/12

Yoga Program for Improving the Quality of Life in Couples Coping With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04607590 Org: User:
Start: 05/31/19 End: 04/30/25 Due: 04/30/26

Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT05038852 Org: User:
Start: 04/12/19 End: 12/31/25 Due: 12/31/26

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

Phase: N/A Priority: Normal
NCT ID: NCT00508443 Org: User:
Start: 10/25/02 End: 10/31/26 Due: 10/31/27

Continuous Glucose Monitoring in Critically Ill

Phase: N/A Priority: Normal
NCT ID: NCT00707434 Org: User:
Start: 06/30/08 End: 09/30/16 Due: 09/30/17